# Theseus Pharmaceuticals, Inc. — Form D

Theseus Pharmaceuticals, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-04. The offering totals $100.1M, of which $95.1M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-02-04
- Form: D
- Accession: 0001745020-21-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $100.1M
- Amount sold: $95.1M
- Remaining: $5.0M
- Investors: 16
- Date of first sale: 2021-01-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388439

## Issuer

- Name: Theseus Pharmaceuticals, Inc.
- CIK: 0001745020
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 210 Broadway, Suite 201, Cambridge, MA, 02139
- Phone: 2127396493

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Iain Dukes | Director | Cambridge, MA |
| Carl C Gordon | Director | New York, NY |
| Michael C Rome | Director | San Francisco, CA |
| William C Shakespeare | Director | Cambridge, MA |
| Iain Dukes | Executive Officer | Cambridge, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-02-04](https://search.stillhousedata.com/formd/0001745020-21-000001) | D/A | $22.1M | $22.1M |
| [2018-06-29](https://search.stillhousedata.com/formd/0001745020-18-000001) | D | $15.0M | $5.0M |

## More

- [CIK 1745020 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1745020&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001745020-21-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.